Dermatologic Clinics

Papers
(The TQCC of Dermatologic Clinics is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Copyright99
Racial and Ethnic Disparities in Research and Clinical Trials45
Diversity, Equity, and Inclusion in Dermatology43
Copyright40
A Canvas of Contemporary Insights into Clinical Vitiligo38
Adnexal and Sebaceous Carcinomas36
Gender Equity in Medicine and Dermatology in the United States26
Psoriasis Comorbidities and Their Treatment Impact24
The Psoriasis Treatment Pipeline22
Cutaneous Sarcoidosis22
A Practical Guide to the Diagnosis, Evaluation, and Treatment of Cutaneous T-Cell Lymphoma21
Coronavirus Disease 2019 and Race in Dermatology21
Contents20
Vascular Anomalies20
From Geraniums to Guadalajara on the Virtues of Early Retirement20
Copyright19
From Clinic to Hospital and Gold Standard to Substandard: The Complexities of Care of Pediatric Patients18
Combination Approaches for Combatting Hair Loss15
Disparities in Care for Psoriasis15
Copyright14
Impact of COVID-19 on Dermatology Residency14
Hidradenitis Suppurativa Management with Antibiotics and Systemic Therapies14
COVID-19 and the Dermatologist14
Pathology of Melanoma13
Using Guidelines of Care to Lower Cardiovascular Risk in Patients with Psoriasis13
Forthcoming Issues13
Diagnosing Disorders of Facial Erythema13
Copyright13
Psoriasis in 2024 and Beyond12
Scalp Infection, Inflammation, and Infestation12
Contributors12
Histopathology of Vascular Tumors12
Contents11
Contents11
Coronavirus Disease 2019 and Dermatology Practice Changes10
Palisaded Neutrophilic Granulomatous Dermatitis, Bowel-Associated Dermatosis–Arthritis Syndrome, and Rheumatoid Neutrophilic Dermatitis10
Starting and Maintaining a Successful Dermatology Practice9
Contributors9
Cutaneous Oncology Update9
The Food and Drug Administration’s Role in Dermatologic Drug Development9
Chemical Peels in Treatment of Melasma9
Histopathology of Vascular Malformations8
Incorporating Cosmetic Procedures into Your Dermatology Practice8
Alopecia Areata7
Understanding and Addressing Microaggressions in Medicine7
Cutaneous Oncology in the Immunosuppressed7
Energy-based Devices for Hair Loss7
Hidradenitis Suppurativa-Related Autoinflammatory Syndromes7
Melanoma classification and management in the era of molecular medicine6
Laser-based and Light-based Therapies in Hidradenitis Suppurativa6
Innovations in Acne6
Clinical Patterns of Hair Loss in Men6
Innovation in Warts and Molluscum5
Private Equity: the Good5
Updates on Lasers in Dermatology5
Genomics in Assessing Melanoma Prognosis5
Food and Drug Administration’s Role in Dermatology5
Achieving the Attractive Asian Midface Profile with Hyaluronic Acid–Based Fillers5
Tips, Tricks, and Pearls to Expertly Treat Common Pediatric Dermatologic Conditions5
Copyright5
The Role of Sunscreen in Protection from Melanoma5
Diversity, Equity, and Inclusion in Dermatology Residency5
Neutrophilic Panniculitides4
Laser Surgery for Dermatologic Conditions in Pediatric Patients4
Hot Topics in Cosmetic Dermatology4
How Does the Food and Drug Administration Approve Topical Generic Drugs Applied to the Skin?4
Contributors4
Addressing Climate-Related Health Impacts During the Patient Encounter4
Innovation in Dermatomyositis4
Capillary Malformations4
The Role of Food Allergy in Atopic Dermatitis4
Quality of Life with Neutrophilic Dermatoses4
Contributors4
Contributors4
Clinical Decisions in Pediatric Psoriasis3
Scarring Alopecia3
Hidradenitis Suppurativa3
Timing of Food Introduction and Allergy Prevention3
Immune Checkpoint Inhibitor-Induced Psoriasis3
Neutrophilic Urticarial Dermatosis3
Contributors3
Collagen Vascular Diseases3
Is Private Practice a Possibility for Me?3
Forthcoming Issues3
Targeted Therapy and Immunotherapy in Melanoma3
Neurotoxin in the Lower Third of the Face3
Clinical Patterns and Morphology of COVID-19 Dermatology3
Cultural Competence and Humility3
Measuring What Matters to Patients in Dermatology Drug Development3
Central Centrifugal Cicatricial Alopecia3
The Role of Genetics on Psoriasis Susceptibility, Comorbidities, and Treatment Response3
Exploring the Association Between Atopic Dermatitis and Malignancy3
Why I’m Still Practicing3
Morbilliform Eruptions in the Hospitalized Child3
Paradoxical Psoriasis3
An Evidence-Based Approach to Pediatric Melanonychia3
Atopic Dermatitis3
Sweet Syndrome and Neutrophilic Dermatosis of the Dorsal Hands3
Dermatologic Consequences of Substandard, Spurious, Falsely Labeled, Falsified, and Counterfeit Medications3
0.18090510368347